Enhanced bone regeneration via endochondral ossification using Exendin-4-modified mesenchymal stem cells

Area of Science:

• Orthopedics
• Regenerative Medicine
• Biomaterials

Background:

• Nonunions and delayed unions present significant orthopedic challenges.
• Current treatments for bone defects are often insufficient.
• Bone tissue engineering (BTE) offers a promising alternative for bone regeneration.

Purpose of the Study:

• To investigate the potential of mesenchymal stem cells overexpressing Exendin-4 (MSC-E4) for bone regeneration.
• To evaluate the efficacy of MSC-E4 in modulating bone remodeling through endochondral ossification (ECO).
• To assess MSC-E4's therapeutic potential in a preclinical bone defect model.

Main Methods:

• Development of a type I collagen (Col-I) sponge-based in vitro model to study ECO.
• Utilizing single-cell sequencing to analyze MSC-E4's effect on cell fate and ECO.
• Encapsulating MSC-E4 in a microscaffold for in vivo testing in a rat calvarial defect model.

Main Results:

• MSC-E4 demonstrated enhanced chondrogenic and hypertrophic differentiation.
• Single-cell sequencing confirmed MSC-E4's superior modulation of the ECO cell fate.
• In vivo studies showed that MSC-E4 facilitated significant bone regeneration in rat calvarial defects.

Conclusions:

• MSC-E4 exhibits potent capabilities for promoting bone regeneration.
• The study advocates for MSC-E4 within a BTE framework for treating critical bone defects.
• Leveraging the intrinsic ECO process with MSC-E4 presents a novel therapeutic strategy.